MedTrace Logo

Protocol Biopsies in High-risk Renal Transplant Recipients

NCT04154267 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 119

Last updated 2023-06-28

No results posted yet for this study

Summary

The present study aims to evaluate the usefulness of protocol biopsies in a cohort of renal transplant patients of high immunological risk for graft injury and loss.

Conditions

  • Kidney Transplant Rejection
  • Kidney Transplant Failure
  • Kidney Transplant Infection
  • Kidney Transplant Failure and Rejection

Interventions

PROCEDURE

Percutaneous renal biopsy.

The biopsy will be performed with a 16 Gauge semi-automatic needle gun for renal biopsy under real-time ultrasound control. After the procedure will be done ultrasound control

Sponsors & Collaborators

  • Hospital de Clinicas de Porto Alegre

    lead OTHER

Principal Investigators

  • Roberto Ceratti Manfro, PhD · Hospital de Clínicas de Porto Alegre

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-01
Primary Completion
2023-12-15
Completion
2024-02-28

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04154267 on ClinicalTrials.gov